Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Romaguera

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Leukemia & Lymphoma|January 1, 1993
Can we identify patients with low grade lymphoma for frontline ABMT?J E Romaguera
The Lancet. Oncology|March 21, 2002
Mantle-cell lymphomaI Barista, J E Romaguera, F Cabanillas
Leukemia & Lymphoma|December 1, 1995
16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphomaJ E Romaguera, J Garcia-Foncillas, F Cabanillas
Hematological Oncology|July 1, 1994
Primary mediastinal large cell lymphomaJ Rodriguez, W C Pugh, J E Romaguera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphomaJ E Romaguera, W Pugh, R Luthra, et al.
Leukemia & Lymphoma|May 9, 2001
Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virusJ Rodriguez, J E Romaguera, R L Katz, et al.
Leukemia & Lymphoma|November 1, 1996
Endocrine characterization of primary mediastinal lymphomaJ E Romaguera, S Meilus, J Rodriguez, et al.
Leukemia & Lymphoma|September 7, 2000
Nasal-type T/NK lymphomas: a clinicopathologic study of 13 casesJ Rodriguez, J E Romaguera, J Manning, et al.
Acta Cytologica|July 1, 1995
Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferationW F Symmans, R L Katz, N G Ordoñez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAPM A Rodriguez, F C Cabanillas, W Velasquez, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Leukemia & Lymphoma|January 1, 1993
Can we identify patients with low grade lymphoma for frontline ABMT?J E Romaguera
The Lancet. Oncology|March 21, 2002
Mantle-cell lymphomaI Barista, J E Romaguera, F Cabanillas
Leukemia & Lymphoma|December 1, 1995
16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphomaJ E Romaguera, J Garcia-Foncillas, F Cabanillas
Hematological Oncology|July 1, 1994
Primary mediastinal large cell lymphomaJ Rodriguez, W C Pugh, J E Romaguera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphomaJ E Romaguera, W Pugh, R Luthra, et al.
Leukemia & Lymphoma|May 9, 2001
Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virusJ Rodriguez, J E Romaguera, R L Katz, et al.
Leukemia & Lymphoma|November 1, 1996
Endocrine characterization of primary mediastinal lymphomaJ E Romaguera, S Meilus, J Rodriguez, et al.
Leukemia & Lymphoma|September 7, 2000
Nasal-type T/NK lymphomas: a clinicopathologic study of 13 casesJ Rodriguez, J E Romaguera, J Manning, et al.
Acta Cytologica|July 1, 1995
Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferationW F Symmans, R L Katz, N G Ordoñez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAPM A Rodriguez, F C Cabanillas, W Velasquez, et al.
Pageof 5